 Paul Seib
Concepts (135)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 3 | 2016 | 328 | 0.390 |
Why?
| | Pulmonary Artery | 2 | 2011 | 147 | 0.390 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2016 | 310 | 0.350 |
Why?
| | Angioplasty, Balloon | 1 | 2010 | 70 | 0.330 |
Why?
| | Arterial Occlusive Diseases | 1 | 2010 | 81 | 0.330 |
Why?
| | Stents | 2 | 2010 | 372 | 0.330 |
Why?
| | Down Syndrome | 2 | 2021 | 93 | 0.290 |
Why?
| | Infant | 14 | 2021 | 3720 | 0.240 |
Why?
| | Heart Defects, Congenital | 2 | 2010 | 622 | 0.240 |
Why?
| | Heart Transplantation | 6 | 2012 | 370 | 0.210 |
Why?
| | Child, Preschool | 13 | 2017 | 4062 | 0.200 |
Why?
| | Cardiac Catheterization | 4 | 2012 | 244 | 0.190 |
Why?
| | Child | 15 | 2021 | 7229 | 0.190 |
Why?
| | DiGeorge Syndrome | 1 | 2021 | 19 | 0.180 |
Why?
| | Tetralogy of Fallot | 1 | 2021 | 85 | 0.170 |
Why?
| | Heart Diseases | 3 | 2012 | 226 | 0.170 |
Why?
| | Heart-Assist Devices | 2 | 2013 | 164 | 0.160 |
Why?
| | Oxygen Consumption | 2 | 2011 | 200 | 0.140 |
Why?
| | Kidney | 2 | 2013 | 723 | 0.140 |
Why?
| | Child, Hospitalized | 1 | 2017 | 32 | 0.140 |
Why?
| | Heart Failure | 2 | 2013 | 587 | 0.130 |
Why?
| | Child Health Services | 1 | 2017 | 78 | 0.130 |
Why?
| | Infant, Newborn | 6 | 2016 | 2891 | 0.130 |
Why?
| | Retrospective Studies | 9 | 2021 | 6671 | 0.130 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 243 | 0.130 |
Why?
| | Treatment Outcome | 8 | 2016 | 5486 | 0.120 |
Why?
| | Heart Arrest | 1 | 2016 | 137 | 0.120 |
Why?
| | Adolescent | 9 | 2016 | 6737 | 0.120 |
Why?
| | Critical Illness | 1 | 2017 | 312 | 0.110 |
Why?
| | Spectroscopy, Near-Infrared | 2 | 2011 | 52 | 0.110 |
Why?
| | Atrial Appendage | 1 | 2012 | 14 | 0.100 |
Why?
| | Dexmedetomidine | 1 | 2012 | 21 | 0.100 |
Why?
| | Fistula | 1 | 2012 | 27 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2012 | 72 | 0.090 |
Why?
| | Aortic Diseases | 1 | 2012 | 55 | 0.090 |
Why?
| | Aorta, Thoracic | 1 | 2012 | 98 | 0.090 |
Why?
| | Fontan Procedure | 1 | 2012 | 68 | 0.090 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2011 | 18 | 0.090 |
Why?
| | Echocardiography | 2 | 2011 | 416 | 0.090 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2012 | 99 | 0.090 |
Why?
| | Kidney Failure, Chronic | 1 | 2013 | 216 | 0.090 |
Why?
| | Humans | 19 | 2021 | 52593 | 0.090 |
Why?
| | Retreatment | 1 | 2010 | 58 | 0.090 |
Why?
| | Constriction, Pathologic | 1 | 2010 | 91 | 0.090 |
Why?
| | Intraoperative Care | 1 | 2010 | 51 | 0.090 |
Why?
| | Echocardiography, Doppler | 1 | 2010 | 56 | 0.080 |
Why?
| | Age Factors | 2 | 2010 | 1132 | 0.080 |
Why?
| | Graft Rejection | 1 | 2010 | 179 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 444 | 0.080 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 485 | 0.080 |
Why?
| | Time Factors | 3 | 2010 | 3000 | 0.080 |
Why?
| | Patient Transfer | 1 | 2010 | 99 | 0.080 |
Why?
| | Recurrence | 1 | 2010 | 683 | 0.080 |
Why?
| | Pipecolic Acids | 1 | 2008 | 7 | 0.080 |
Why?
| | Cesium | 1 | 2008 | 8 | 0.070 |
Why?
| | Chlorides | 1 | 2008 | 43 | 0.070 |
Why?
| | Oxygen | 1 | 2011 | 336 | 0.070 |
Why?
| | Jugular Veins | 1 | 2008 | 32 | 0.070 |
Why?
| | Drug-Eluting Stents | 1 | 2008 | 102 | 0.070 |
Why?
| | Superior Vena Cava Syndrome | 1 | 2007 | 11 | 0.070 |
Why?
| | Arkansas | 2 | 2010 | 2029 | 0.070 |
Why?
| | Heparin | 1 | 2008 | 89 | 0.070 |
Why?
| | Male | 12 | 2017 | 26863 | 0.070 |
Why?
| | Coronary Disease | 1 | 2008 | 165 | 0.070 |
Why?
| | Thrombocytopenia | 1 | 2008 | 92 | 0.070 |
Why?
| | Female | 12 | 2017 | 28262 | 0.070 |
Why?
| | Decision Making | 1 | 2010 | 282 | 0.070 |
Why?
| | Catheterization, Central Venous | 1 | 2008 | 82 | 0.070 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2008 | 176 | 0.070 |
Why?
| | Electrocardiography | 1 | 2008 | 281 | 0.060 |
Why?
| | Risk Factors | 2 | 2016 | 3952 | 0.060 |
Why?
| | Oximetry | 1 | 2007 | 66 | 0.060 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2007 | 123 | 0.060 |
Why?
| | Vascular Malformations | 1 | 2008 | 103 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 2007 | 129 | 0.060 |
Why?
| | Risk Assessment | 1 | 2010 | 1350 | 0.060 |
Why?
| | Cerebral Cortex | 1 | 2007 | 195 | 0.060 |
Why?
| | Anticoagulants | 1 | 2008 | 279 | 0.060 |
Why?
| | Hospital Mortality | 2 | 2016 | 459 | 0.050 |
Why?
| | Databases, Factual | 2 | 2017 | 715 | 0.050 |
Why?
| | Odds Ratio | 2 | 2017 | 568 | 0.050 |
Why?
| | Young Adult | 1 | 2010 | 4337 | 0.040 |
Why?
| | Hospitals | 1 | 2021 | 184 | 0.040 |
Why?
| | Length of Stay | 2 | 2016 | 674 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2011 | 1217 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 188 | 0.030 |
Why?
| | Critical Care | 1 | 2017 | 222 | 0.030 |
Why?
| | Prospective Studies | 2 | 2011 | 2457 | 0.030 |
Why?
| | Incidence | 1 | 2016 | 1077 | 0.030 |
Why?
| | Aortography | 1 | 2012 | 33 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 196 | 0.020 |
Why?
| | Radiography, Interventional | 1 | 2012 | 58 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 295 | 0.020 |
Why?
| | Patient Safety | 1 | 2012 | 104 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 288 | 0.020 |
Why?
| | Diastole | 1 | 2011 | 68 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2011 | 95 | 0.020 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2011 | 26 | 0.020 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2010 | 8 | 0.020 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2010 | 22 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2010 | 17 | 0.020 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2010 | 24 | 0.020 |
Why?
| | Ventricular Function, Right | 1 | 2010 | 41 | 0.020 |
Why?
| | Mitral Valve | 1 | 2010 | 57 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 254 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2012 | 1202 | 0.020 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2010 | 158 | 0.020 |
Why?
| | Blood Pressure | 1 | 2011 | 537 | 0.020 |
Why?
| | Dipyridamole | 1 | 2008 | 8 | 0.020 |
Why?
| | Heparin Antagonists | 1 | 2008 | 7 | 0.020 |
Why?
| | Protamines | 1 | 2008 | 8 | 0.020 |
Why?
| | Thrombin | 1 | 2008 | 38 | 0.020 |
Why?
| | International Normalized Ratio | 1 | 2008 | 28 | 0.020 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2008 | 41 | 0.020 |
Why?
| | Biopsy | 1 | 2010 | 607 | 0.020 |
Why?
| | Program Evaluation | 1 | 2010 | 353 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 205 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2008 | 222 | 0.020 |
Why?
| | Logistic Models | 1 | 2010 | 934 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 952 | 0.020 |
Why?
| | Warfarin | 1 | 2008 | 84 | 0.020 |
Why?
| | Angiography | 1 | 2007 | 114 | 0.020 |
Why?
| | Sulfonamides | 1 | 2008 | 134 | 0.020 |
Why?
| | Patient Compliance | 1 | 2008 | 230 | 0.020 |
Why?
| | Aspirin | 1 | 2008 | 123 | 0.020 |
Why?
| | Arginine | 1 | 2008 | 182 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2008 | 388 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2008 | 213 | 0.020 |
Why?
| | United States | 1 | 2017 | 5227 | 0.020 |
Why?
| | Postoperative Period | 1 | 2007 | 172 | 0.020 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 200 | 0.020 |
Why?
| | Cohort Studies | 1 | 2010 | 1553 | 0.020 |
Why?
| | Liver Neoplasms | 1 | 2008 | 332 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2010 | 1162 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 2291 | 0.010 |
Why?
|
|
Seib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|